drug protocol number

GB002-3102

drug sponsor

GB002, Inc / Balsam

drug study

Seralutinib

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh) , King Fahad Medical City (Riyadh)

drug status

Ongoing

drug phase